Literature DB >> 6365919

Escherichia coli pyruvate dehydrogenase complex. Thiamin pyrophosphate-dependent inactivation by 3-bromopyruvate.

M A Apfel, B H Ikeda, D C Speckhard, P A Frey.   

Abstract

Inactivation of the pyruvate dehydrogenase complex by 3-bromopyruvate is thiamin pyrophosphate (TPP)-dependent. Inactivation with 2-14C- or 3-14C-labeled 3-bromopyruvate results in TPP-dependent covalent labeling of more than 60 sites in the complex, all of which are associated with the dihydrolipoyl transacetylase component. Inactivation by 3-bromo[1-14C]pyruvate labels up to 20 sites associated with dihydrolipoyl transacetylase, also with TPP dependence. Systemic chemical degradation of the complex inactivated by 3-bromo[2-14C]pyruvate under conditions that would convert lipoyl groups to S,S,-biscarboxymethyl dihydrolipoic acid produces S,S,-bis[14C]carboxymethyl dihydrolipoic acid. It is concluded that 3-bromopyruvate inactivates this complex by initially undergoing the first two steps of the usual catalytic pathway, TPP-dependent decarboxylation followed by reductive bromoacetylation of lipoyl moieties. The sulfhydryl groups of S-bromoacetyl dihydrolipoyl moieties generated by reductive bromoacetylation are then alkylated by 3-bromopyruvate as well as by bromoacetyl thioester groups associated with the complex.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6365919

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Inactivation of pyruvate decarboxylase by 3-hydroxypyruvate.

Authors:  G Thomas; R Diefenbach; R G Duggleby
Journal:  Biochem J       Date:  1990-02-15       Impact factor: 3.857

2.  Activation of insulin-secreting cells by pyruvate and halogenated derivatives.

Authors:  A P Yates; A M Lynch; L Best
Journal:  Biochem J       Date:  1990-01-01       Impact factor: 3.857

Review 3.  3-Bromopyruvate: targets and outcomes.

Authors:  Maria C Shoshan
Journal:  J Bioenerg Biomembr       Date:  2012-02       Impact factor: 2.945

4.  Inhibition of pyruvate:ferredoxin oxidoreductase from Trichomonas vaginalis by pyruvate and its analogues. Comparison with the pyruvate decarboxylase component of the pyruvate dehydrogenase complex.

Authors:  K P Williams; P F Leadlay; P N Lowe
Journal:  Biochem J       Date:  1990-05-15       Impact factor: 3.857

Review 5.  Targeting aerobic glycolysis: 3-bromopyruvate as a promising anticancer drug.

Authors:  Simone Cardaci; Enrico Desideri; Maria Rosa Ciriolo
Journal:  J Bioenerg Biomembr       Date:  2012-02       Impact factor: 2.945

6.  Peptide Transporter CstA Imports Pyruvate in Escherichia coli K-12.

Authors:  Soonkyu Hwang; Donghui Choe; Minseob Yoo; Sanghyuk Cho; Sun Chang Kim; Suhyung Cho; Byung-Kwan Cho
Journal:  J Bacteriol       Date:  2018-03-12       Impact factor: 3.490

7.  Characterization of LrgAB as a stationary phase-specific pyruvate uptake system in Streptococcus mutans.

Authors:  Sang-Joon Ahn; Kamal Deep; Matthew E Turner; Ivan Ishkov; Anthony Waters; Stephen J Hagen; Kelly C Rice
Journal:  BMC Microbiol       Date:  2019-10-12       Impact factor: 3.605

8.  Regulation of cid and lrg expression by CodY in Streptococcus mutans.

Authors:  Sang-Joon Ahn; Hey-Min Kim; Shailja Desai; Kamal Deep; Kelly C Rice
Journal:  Microbiologyopen       Date:  2020-04-13       Impact factor: 3.139

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.